Vesical vs. extra-vesical patterns of recurrence after the treatment of urothelial upper tract tumors

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 3, 2008, Pages 266-270

  Shikanov, Sergey ^a   Shapiro, Amos ^a   Baer, Lea ^a   Landau, Ezekiel H ^a   Katz, Ran ^a   Gofrit, Ofer N ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Follow up; Recurrence; Urothelial upper tract tumors

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; VINBLASTINE;

ABDOMINAL RADIOGRAPHY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTOSCOPY; DISEASE FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; NEUTROPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; THORAX RADIOGRAPHY; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; URINARY TRACT; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; URETHRAL NEOPLASMS;

EID: 42949118818     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.04.007     Document Type: Article

References (24)

1. Raman J.D., Ng C.K., Boorjian S.A., et al. Bladder cancer after managing upper urinary tract transitional cell carcinoma: Predictive factors and pathology. BJU Int 96 (2005) 1031-1035
2. Koga F., Nagamatsu H., Ishimaru H., et al. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. Urol Int 67 (2001) 135-141
3. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology 52 (1998) 594-601
4. Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65 (2005) 279-283
5. Hisataki T., Miyao N., Masumori N., et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology 55 (2000) 663-667
6. Kang C.H., Yu T.J., Hsieh H.H., et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98 (2003) 1620-1626
7. Cozad S.C., Smalley S.R., Austenfeld M., et al. Transitional cell carcinoma of the renal pelvis or ureter: Patterns of failure. Urology 46 (1995) 796-800
8. Bamias A., Deliveliotis C., Fountzilas G., et al. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: A study by the Hellenic Cooperative Oncology Group. J Clin Oncol 22 (2004) 2150-2154
9. Lerner S.E., Blute M.L., Richardson R.L., et al. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract. Mayo Clin Proc 71 (1996) 945-950
10. Redman B.G., Smith D.C., Flaherty L., et al. Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma. J Clin Oncol 16 (1998) 1844-1848
11. Igawa M., Ohkuchi T., Ueki T., et al. Usefulness and limitations of methotrexate, vinblastine, doxorubicin, and cisplatin for the treatment of advanced urothelial cancer. J Urol 144 (1990) 662-665
12. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
13. Fechner G., Siener R., Reimann M., et al., German Association Of Urologic Oncology (AUO) Bladder Cancer Study Group. Randomized phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99). Int J Clin Pract 60 (2006) 27-31
14. Rosenberg J.E., Carroll P.R., and Small E.J. Update on chemotherapy for advanced bladder cancer. J Urol 174 (2005) 14-20
15. Canfield S.E., Dinney C.P., and Droller M.J. Surveillance and management of recurrence for upper tract transitional cell carcinoma. Urol Clin North Am 30 (2003) 791-802
16. Kwiatowski D.J., Harpole Jr. D.H., Godleski J.U., and International Union against Cancer (IUCC). Urinary bladder. In: Sobin L.H., and Wittekind C.H. (Eds). TNM classification of Malignant Tumors (1997), Wiley-Liss, New York 187-190
17. Epstein J.I., Amin M.B., Reuter V.R., et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22 (1998) 1435-1448
18. Shipley W.U., Kaufman D.S., Heney N.M., et al. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy. J Urol 162 (1999) 445-450
19. Herr H.W., Bajorin D.F., and Scher H. Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: Ten-year outcome. J Clin Oncol 16 (1998) 1298-1301
20. Kurth K.H., Denis L., Bouffioux C., et al. Factors affecting recurrence and progression in superficial bladder tumors. Eur J Cancer 31A (1995) 1840-1846
21. Jabbour M.E., and Smith A.D. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am 16 (2000) 483-487
22. Canfield S.E., Dinney C.P., and Droller M.J. Surveillance and management of recurrence for upper tract transitional cell carcinoma. Urol Clin North Am 30 (2003) 791-802
23. Duggan B.J., Gray S.B., McKnight J.J., et al. Oligoclonality in bladder cancer: The implication for molecular therapies. J Urol 171 (2004) 419-425
24. Holmang S., and Johansson S.L. Bilateral metachronous ureteral and renal pelvic carcinomas: Incidence, clinical presentation, histopathology, treatment, and outcome. J Urol 175 (2006) 69-72